Skip to Content

Laser Improves QOL for Breast Telangiectasia Due to Radiation

TUESDAY, Jan. 2, 2018 -- Laser monotherapy improves health-related quality of life (HR-QOL) in female patients with radiation-induced breast telangiectasias (RIBT), according to a study published online Dec. 20 in Lasers in Surgery and Medicine.

Anthony M. Rossi, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a prospective study at their institution involving breast cancer patients with chronic radiation dermatitis. Twenty-two female patients with RIBT completed HR-QOL questionnaires before and after laser monotherapy.

The researchers found that 13 of the patients exhibited telangiectasias across the d├ęcolletage and axilla as well as the breast. During the study period, 16 patients reached the 50 percent RIBT clearance threshold and 11 of these patients (69 percent) completed HR-QOL questionnaires at follow-up. Statistically significant improvements were seen in emotional and functional Skindex-16 HR-QOL domains and in overall Skindex-16 HR-QOL score. There was also significant improvement in Breast-Q Adverse Effects of Radiation scores, showing a decrease in specific physical and cosmetic concerns that affect radiated breast skin. Transient post-treatment pain and redness were common adverse events.

"Breast cancer patients with RIBT presented with substantial deficits in several HR-QOL arenas," the authors write. "Laser monotherapy effectively treated the appearance of radiation dermatitis in these patients and also significantly improved HR-QOL."

Abstract
Full Text (subscription or payment may be required)

© 2019 HealthDay. All rights reserved.

Posted: January 2018

Hide